Skip to main content
L&C BIO Co., Ltd logo

L&C BIO Co., Ltd — Investor Relations & Filings

Ticker · 290650 ISIN · KR7290650001 KO Manufacturing
Open in API
Filings indexed 378 across all filing types
Latest filing 2020-06-25 Transaction in Own Shar…
Country KR South Korea
Listing KO 290650

About L&C BIO Co., Ltd

http://www.lncbio.co.kr/?locale=en_US

L&C BIO Co., Ltd. is a biotechnology company specializing in regenerative medicine. The company develops, manufactures, and commercializes human tissue-based medical devices and allograft treatment materials. Its core operations include the processing, storage, and distribution of human tissues, with a focus on skin, musculoskeletal, and soft tissues, utilizing patented processing technologies. The company's product portfolio also extends to other medical devices and cosmetics. L&C BIO supports its activities through dedicated research and development centers and manufacturing facilities, including a human tissue plant and a pharmaceutical plant, to advance its pipeline and serve global markets.

Recent filings

Filing Released Lang Actions
자기주식취득결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a '자기주식취득결과보고서' (Report on the Results of Treasury Stock Acquisition) filed with the Financial Supervisory Service (FSS) in South Korea. It details the specific dates, quantities, and prices of shares repurchased by the company (L&C Bio) over a specific period. This falls directly under the category of 'Transaction in Own Shares' (POS), which covers share buybacks.
2020-06-25 Korean
[기재정정]주식소각결정
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from L&C Bio regarding a 'Decision to Cancel Shares' (주식소각 결정). It details the correction of share cancellation amounts and dates, confirming the acquisition and subsequent cancellation of treasury shares. This falls under the category of share capital changes or corporate actions related to treasury shares, which is best classified as 'Transaction in Own Shares' (POS) as it specifically details the buyback and cancellation process.
2020-06-25 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in shareholding, and collateral agreements of a major shareholder (Lee Whan-chul) in L&C Bio. This document type corresponds to the 'Major Shareholding Notification' category, as it tracks significant ownership levels and changes in control.
2020-06-17 Korean
주요사항보고서(자기주식취득결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) from L&C Bio regarding a decision to acquire treasury shares (자기주식 취득 결정). This is a formal regulatory filing detailing a share buyback program, which falls under the category of a company buying back its own shares.
2020-06-15 Korean
주식소각결정
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from L&C Bio regarding a decision to cancel shares (stock incineration). It details the number of shares to be cancelled, the method of acquisition (buyback), the timeline, and the legal basis for the action. This falls under the category of capital changes and share buyback/cancellation activities, which is best classified as 'Transaction in Own Shares' (POS) as it specifically details the company's plan to acquire and subsequently cancel its own shares.
2020-06-15 Korean
타법인주식및출자증권취득결정(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system (KIND) regarding a company's decision to acquire shares in another entity (a Chinese subsidiary). This type of disclosure, detailing the acquisition of equity, investment purpose, and financial impact, is classified as a general regulatory announcement under the RNS category, as it does not fit into specific categories like M&A (which usually implies a merger or takeover of a public entity) or other specialized financial reports.
2020-06-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.